PLSE (Pulse Biosciences, Inc.) Stock Financials & Earnings

PLSEPulse Biosciences, Inc.

Mkt Cap$1B

Revenue (TTM)$350,000

Net Income (TTM)-$73M

EPS (TTM)-$1.08

Free Cash Flow (TTM)-$54M

Gross Margin-204.3%

Op. Margin-21982.6%

Net Margin-20794.6%

FCF Margin-15553.4%

P/S Ratio (TTM)3714.7x

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$10M
Q2 23	$0	$0	-$10M
Q3 23	$0	$0	-$11M
Q4 23	$0	$0	-$13M
Q1 24	$0	-$299K	-$11M
Q2 24	$0	$0	-$12M
Q3 24	$0	$0	-$14M
Q4 24	$0	$0	-$20M
Q1 25	$0	$0	-$18M
Q2 25	$0	-$267K	-$20M
Q3 25	$86K	-$193K	-$20M
Q4 25	$264K	-$255K	-$18M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$6M	$4M	—
Q2 23	$7M	$4M	—
Q3 23	$7M	$4M	—
Q4 23	$8M	$5M	—
Q1 24	$7M	$4M	—
Q2 24	$7M	$4M	—
Q3 24	$8M	$6M	—
Q4 24	$11M	$10M	—
Q1 25	$10M	$8M	—
Q2 25	$12M	$8M	—
Q3 25	$11M	—	$9M
Q4 25	$11M	—	$7M

Revenue Segments

Quarter

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$54M	$0	$54M
Q2 23	$59M	$0	$59M
Q3 23	$50M	$0	$50M
Q4 23	$44M	$0	$44M
Q1 24	$35M	$0	$35M
Q2 24	$26M	$0	$26M
Q3 24	$79M	$0	$79M
Q4 24	$118M	$0	$118M
Q1 25	$119M	$0	$119M
Q2 25	$106M	$0	$106M
Q3 25	$95M	$0	$95M
Q4 25	$81M	$0	$81M

Shares Outstanding

Revenue Per Employee

Revenue / Employee